当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析 - 现金流量表

泓博医药

(301230)

  

流通市值:29.01亿  总市值:52.69亿
流通股本:7686.03万   总股本:1.40亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金259,334,867.87118,756,546.12492,920,297.82341,354,162.95
  收到的税费返还3,708,973.081,550,598.575,535,005.085,202,469.14
  收到其他与经营活动有关的现金18,208,955.727,771,632.2940,895,944.840,800,565.52
  经营活动现金流入小计281,252,796.67128,078,776.98539,351,247.7387,357,197.61
  购买商品、接受劳务支付的现金78,928,149.4335,047,705.46161,717,483.11111,079,274.98
  支付给职工以及为职工支付的现金124,075,199.2467,052,885.29241,642,844.21170,382,864.61
  支付的各项税费8,623,129.883,223,408.1410,701,325.1413,396,998.76
  支付其他与经营活动有关的现金30,200,189.3824,631,085.9944,426,065.4971,391,026.78
  经营活动现金流出小计241,826,667.93129,955,084.88458,487,717.95366,250,165.13
  经营活动产生的现金流量净额39,426,128.74-1,876,307.980,863,529.7521,107,032.48
二、投资活动产生的现金流量:
  收回投资收到的现金20,000,00010,000,000619,392,000589,725,375
  取得投资收益收到的现金105,380.5359,178.083,435,499.975,573,746.29
  处置固定资产、无形资产和其他长期资产收回的现金净额--145,86450,000
  收到的其他与投资活动有关的现金---1,897,510.26
  投资活动现金流入小计20,105,380.5310,059,178.08622,973,363.97597,246,631.55
  购建固定资产、无形资产和其他长期资产支付的现金17,276,315.26,339,135.58109,403,592.8271,106,905.98
  投资支付的现金10,000,00010,000,000558,392,000516,392,000
  支付其他与投资活动有关的现金---2,654,750
  投资活动现金流出小计27,276,315.216,339,135.58667,795,592.82590,153,655.98
  投资活动产生的现金流量净额-7,170,934.67-6,279,957.5-44,822,228.857,092,975.57
三、筹资活动产生的现金流量:
  取得借款收到的现金20,664,755.587,653,171.3419,654,670.8919,654,670.89
  筹资活动现金流入小计20,664,755.587,653,171.3419,654,670.8919,654,670.89
  偿还债务支付的现金10,000,000-25,564,355.0323,247,603.63
  分配股利、利润或偿付利息支付的现金173,00090,00049,273,544.9935,465,655.78
  支付其他与筹资活动有关的现金13,751,858.96,231,483.5582,422,898.6671,928,620.13
  筹资活动现金流出小计23,924,858.96,321,483.55157,260,798.68130,641,879.54
  筹资活动产生的现金流量净额-3,260,103.321,331,687.79-137,606,127.79-110,987,208.65
四、汇率变动对现金及现金等价物的影响2,110,7281,322,735.544,816,818.382,791,150.46
五、现金及现金等价物净增加额31,105,818.75-5,501,842.07-96,748,008.51-79,996,050.14
  加:期初现金及现金等价物余额38,748,947.1738,748,947.17135,496,955.68135,496,955.68
  期末现金及现金等价物余额69,854,765.9233,247,105.138,748,947.1755,500,905.54
补充资料:
  净利润24,761,426.27-17,083,154.83-
  资产减值准备5,159,549.6-643,810.61-
  固定资产和投资性房地产折旧13,817,549.06-25,702,048.59-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧13,817,549.06-25,702,048.59-
  无形资产摊销246,229.07-457,672.51-
  长期待摊费用摊销21,408,810.13-28,571,817.53-
  固定资产报废损失76,317.06-287,018.07-
  公允价值变动损失-3,313,005.94--4,971,768.04-
  财务费用2,061,838.73-4,459,644.41-
  投资损失-105,380.53--3,435,499.97-
  递延所得税-8,508,051.84--20,829,721.24-
  其中:递延所得税资产减少-8,819,118.59--20,510,177.87-
    递延所得税负债增加311,066.75--319,543.37-
  存货的减少3,102,121.71--4,368,975.16-
  经营性应收项目的减少-58,386,299.29-7,106,877.54-
  经营性应付项目的增加24,833,860.84-7,249,240.07-
  其他2,817,058.87---
  现金的期末余额69,854,765.92-38,748,947.17-
  减:现金的期初余额38,748,947.17-135,496,955.68-
  现金及现金等价物的净增加额31,105,818.75--96,748,008.51-
公告日期2025-08-282025-04-292025-04-242024-10-28
审计意见(境内)标准无保留意见
TOP↑